IBS therapy, Pain Therapeutics
MorViva
Naltrexone (low-dose), Pain Therapeutics
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
Naltrexone base anhydrous
5S6W795CQM
Naltrexonum
AB00174152_17
PDSP2_000847
Prestwick2_000116
BSPBio_000132
SMP1_000206
cid_5485201
Vivitrol
DQCKKXVULJGBQN-XFWGSAIBSA-N
GTPL1639
MCULE-7032963403
Naltrel
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0;{1,13}.0;{5,17}.0;{7,18}]octadeca-7(18),8,10-trien-14-one
naltrexone (ReVia)
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-
Naltrexone depot (injectable suspension), elbion
88088-EP2275420A1
NCGC00024427-04
BCP07022
PTI-901
CCRIS 3506
Tox21_112007_1
D05113
XR-NTX
DSSTox_RID_81532
HSDB 6750
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-
Naltrexona [INN-Spanish]
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride
Naltrexone (transdermal, alcohol/opioid dependence), Syntropharma
3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one
Naltrexone [USAN:BAN:INN]
88088-EP2305648A1
Nemexin
BIDD:GT0405
BRD-K88172511-310-03-8
SC-94535
US9107954, naltrexone
DB00704
EN-1639A [AS HYDROCHLORIDE]
Irritable bowel syndrome therapy, Pain Therapeutics
N-Cyclopropylmethyl-14-hydroxydihydromorphinone
(-)-Naltrexone
Naltrexone (once-monthly controlled-release, Medisorb), Alkermes
Naltrexone Depot
Naltrexonum [INN-Latin]
AKOS015994596
Prestwick0_000116
Prestwick3_000116
C07253
SPBio_002071
CS-0880
Vivitrol (TN)
DSSTox_CID_26313
HMS2089O11
MolPort-004-920-221
Naltrexon
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one
Naltrexone (sustained release), DAS
17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one
Naltrexone hydrochloride
88088-EP2298761A1
NCGC00024427-05
BDBM50000787
BPBio1_000146
PubChem24168
Celupan
UM-792
D0PG8O
ZINC1773
DTXSID4046313
HY-76711
Morphinan-6-one,17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5a)-
(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one
Naltrexone (USAN/INN)
Naltrexone [USAN:INN:BAN]
AB00174152-14
Opioid antagonists (irritable bowel syndrome), Pain Therapeutics
BRN 3596648
SCHEMBL34681
CHEMBL19019
Vivitrex
Depotrex
FT-0696752
LS-92094
N-Cyclopropylmethylnoroxymorphone
(-)naltrexone
Naltrexone (polymer microcapsule depot, opioid addiction/alcohol dependency), Biotek
16590-41-3
Naltrexone depot (injectable suspension), DrugAbuse Sciences
88088-EP2270005A1
NCGC00024427-03
AN-12941
Prestwick1_000116
PTI-555
CAS-16590-41-3
Tox21_112007
cyclopropylmethyl(dihydroxy)[?]one
W-5099
DSSTox_GSID_46313
HS-0002
Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-
Naltrexona
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-trien-14-one
Naltrexone (sustained release), elbion
17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one
Naltrexone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
88088-EP2298776A1
NCGC00162274-02
BDBM60212